Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

84.92
+0.21000.25%
Volume:5.44M
Turnover:459.67M
Market Cap:213.69B
PE:12.35
High:85.83
Open:85.27
Low:83.79
Close:84.71
Loading ...

Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential

Insider Monkey
·
Yesterday

Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now

Motley Fool
·
Yesterday

Guggenheim Adjusts Merck & Co.'s Price Target to $108 From $115

MT Newswires Live
·
Yesterday

Merck Begins Construction of $1 Billion Biologics Facility in Delaware

MT Newswires Live
·
29 Apr

Immutep Quarterly Activities Report Q3 FY25

GlobeNewswire
·
29 Apr

BRIEF-Merck Breaks Ground On New $1 Billion Biologics Center Of Excellence In Wilmington, Delaware

Reuters
·
29 Apr

Merck starts construction on new $1B biologics center in Delaware

TIPRANKS
·
29 Apr

Merck & Co Inc: Merck Wilmington Biotech Will Serve as a Launch and Commercial Production Facility and Future U.S. Home for Keytruda

THOMSON REUTERS
·
29 Apr

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

THOMSON REUTERS
·
29 Apr

Merck & Co Inc - New Facility to Create 500 Full-Time Roles and 4,000 Jobs

THOMSON REUTERS
·
29 Apr

Merck & Co: Laboratory Component Is Expected to Be Fully Operational by 2028, With Production of Investigational Compounds to Start by 2030

THOMSON REUTERS
·
29 Apr

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

Business Wire
·
29 Apr

Ireland's Economy Surges as U.S. Businesses Stockpile Ahead of Possible Tariffs -- Update

Dow Jones
·
29 Apr

Merck to invest $1 billion in new Delaware plant to boost US manufacturing, WSJ reports

Reuters
·
29 Apr

BRIEF-Merck To Spend $1 Billion On New Factory To Make U.S. Supplies Of Cancer Drug Keytruda- WSJ

Reuters
·
29 Apr

Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Cancer Drug Keytruda- WSJ

THOMSON REUTERS
·
29 Apr

Smead Value Fund's Strategic Move: Millrose Properties Inc. Takes Center Stage

GuruFocus.com
·
29 Apr

Merck (NYSE:MRK) Presents Promising KEYTRUDA Trial Data at AACR 2025 Meeting

Simply Wall St.
·
29 Apr

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

GlobeNewswire
·
28 Apr

U.S. Stocks to Watch: Tesla, Domino's, Nvidia, Merck, Spirit AeroSystems, and More

Dow Jones
·
28 Apr